Liegang Shao

Title: The Innovations of Liegang Shao

Introduction

Liegang Shao is a prominent inventor based in Suzhou, China. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on innovative solutions for cancer treatment, showcasing his commitment to advancing medical science.

Latest Patents

Liegang Shao holds a patent for TIM-3-targeting antibodies and their uses. This patent discloses anti-TIM-3 antibodies and antigen-binding fragments, along with polynucleotides encoding these antibodies. Additionally, it includes pharmaceutical compositions that comprise the antibodies and fragments. The patent also outlines the potential applications of these anti-TIM-3 antibodies in cancer treatment, highlighting their importance in therapeutic strategies.

Career Highlights

Shao is associated with Suzhou Neologics Bioscience Co., Ltd., where he continues to innovate in the field of bioscience. His work at the company emphasizes the development of cutting-edge therapies that can significantly impact patient care and treatment outcomes.

Collaborations

Liegang Shao collaborates with notable colleagues, including Xin Dong and Jinyu Dong. These partnerships enhance the research and development efforts at Suzhou Neologics Bioscience Co., Ltd., fostering a collaborative environment that drives innovation.

Conclusion

Liegang Shao's contributions to the field of biotechnology, particularly through his patent on TIM-3-targeting antibodies, demonstrate his dedication to improving cancer treatment. His work continues to inspire advancements in medical science and therapeutic development.